Objectives
- To determine if mortality (overall and cancer-related) is increased in a population-based sample of adult individuals treated with growth hormone in childhood.
- To analyse risks of overall and cause-specific mortality in relation to dose, duration, age of GH treatment, time since GH treatment, and relation to background condition for which treatment was given.
|
WP leader: institute of Cancer Research, University of London UK
Pr Anthony Swederlow